Healthcare Services

Advancements In Two-Part Media Systems Accelerating Therapeutic Protein Production Is Affecting The Direction Of The Mammalian Cell Culture Market

June 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Will Be The Estimated Market Size Of The Mammalian Cell Culture Market By 2030?

In recent years, the mammalian cell culture market size has expanded quickly. It is forecast to grow from $4.86 billion in 2025 to $5.4 billion in 2026, at a compound annual growth rate (CAGR) of 11.1%. The historical expansion can be linked to the increased production of monoclonal antibodies, an uptick in vaccine manufacturing capacity, the growing application of mammalian cells in drug discovery, the wider availability of advanced culture equipment, and the advancement of biopharmaceutical research.

The mammalian cell culture market is anticipated to experience substantial expansion over the coming years. Its value is projected to reach $8.13 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.8%. This forecasted growth is primarily driven by heightened investments in cell and gene therapy, an escalating need for biologics production, the broadening scope of regenerative medicine research, an intensifying emphasis on scalable cell culture technologies, and the increased integration of continuous bioprocessing methods. Key trends expected during this period involve the greater uptake of serum-free mammalian cell culture media, a surge in demand for large-scale biopharmaceutical manufacturing, the expanding deployment of automated cell culture systems, the broadening of cell-based vaccine production, and a heightened commitment to ensuring process consistency and maximizing yield.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=30318&type=smp

What Influential Factors Are Boosting The Mammalian Cell Culture Market Demand?

The growing need for personalized medicine is anticipated to drive the expansion of the mammalian cell culture market in the future. Personalized medicine involves tailoring medical interventions to an individual’s genetic makeup, environmental influences, and lifestyle choices, resulting in more potent and accurate healthcare. The surge in personalized medicine’s popularity stems from its enhanced treatment efficacy, as it adapts therapies to unique genetic and biological characteristics, thereby improving patient results. Mammalian cell culture facilitates personalized medicine by offering a regulated setting to examine cells specific to a patient, which permits the creation of customized treatments and the evaluation of drug reactions for highly accurate and potent interventions. As an illustration, in February 2024, the Personalized Medicine Coalition, a US-based non-profit entity, stated that during 2023, the FDA granted approval to 16 novel personalized treatments for individuals suffering from rare diseases, marking a considerable rise from the six approved in 2022. Consequently, the escalating need for personalized medicine is fueling the expansion of the mammalian cell culture market.

Which Segment-Based Categories Are Covered In The Mammalian Cell Culture Market?

The mammalian cell culture market covered in this report is segmented –

1) By Product: Media, Sera, Reagents, Equipment

2) By Cell Line: Chinese Hamster Ovary (CHO), Wistar Institute-38 (WI-38), Rat Glial Tumor Cell Line (C6), Human Embryonic Kidney 293 (HEK293), Henrietta Lacks (HeLa)

3) By Application: Biopharmaceutical Production, Vaccine Production, Toxicity Testing, Drug Screening and Development, Tissue Engineering And Regenerative Medicine

4) By End-Use: Pharmaceutical And Biotechnology Companies, Hospitals And Diagnostic Laboratories, Research And Academic Institutes, Contract Research Organizations (CROs)

Subsegments:

1) By Media: Serum-free Media, Chemically Defined Media, Classical Media, Protein-free Media, Specialty Media, Custom Media Formulations

2) By Sera: Fetal Bovine Serum (FBS), Newborn Calf Serum, Adult Bovine Serum, Donor Horse Serum

3) By Reagents: Growth Factors And Cytokines, Cell Dissociation Reagents, Supplements And Additives, Cryoprotective Agents, Buffers And Salt Solutions, Antibiotics And Antimycotics

4) By Equipment: Bioreactors And Fermenters, Culture Vessels, Filtration Systems, Centrifuges, Cell Counters And Analyzers, Incubators, Biosafety Cabinets, Microscopes, Refrigeration And Cryostorage Equipment

Which Trends Are Supporting The Evolution Of The Mammalian Cell Culture Market?

Major companies in the mammalian cell culture market are concentrating on innovations in cell culture media, including two-part production systems, to increase protein yield, enhance cell viability, and streamline scalable bioprocess workflows for therapeutic applications. A two-part production system is a cell culture strategy employing two distinct media components: one to support general cell growth and another to intensify protein expression, thereby enabling improved productivity. For instance, Lonza Group Ltd., a Switzerland-based contract development and manufacturing organization (CDMO), launched the TheraPRO CHO Media System in July 2023. This advanced platform is a chemically defined, animal-component-free cell culture media specifically formulated for GS-CHO mammalian cell lines. The system’s objective is to enhance the production of therapeutic proteins and monoclonal antibodies by delivering higher cell viability and improved protein yields. Its scalable architecture supports all phases of bioprocess manufacturing, from initial cell line development to extensive large-scale production. With this launch, Lonza endeavors to streamline workflows, improve product quality, and accelerate time-to-market for biopharmaceutical manufacturers.

Who Are The Firms Contributing To The Mammalian Cell Culture Market Ecosystem?

Major companies operating in the mammalian cell culture market are Novartis AG, Thermo Fisher Scientific Inc., Merck KGaA, Danaher Corporation, GE Healthcare, Becton Dickinson and Company, Lonza Group AG, Avantor Inc., Agilent Technologies Inc., Charles river laboratories, Sartorius AG, Samsung biologics, Wuxi biologics, Bio-Techne Corporation, Miltenyi Biotec, STEMCELL Technologies, Takara Bio Inc., Goodwin biotechnology, HiMedia Laboratories Private Limited, Promocell GmbH, Eppendorf AG, Cell Culture Company LLC, Cell X Technologies.

Access The Complete Mammalian Cell Culture Market Report:

https://www.thebusinessresearchcompany.com/report/global-mammalian-cell-culture-market-report

Which Region Holds The Largest Share In The Mammalian Cell Culture Market?

North America was the largest region in the mammalian cell culture market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mammalian cell culture market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Mammalian Cell Culture Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=30318&type=smp

Browse Through More Reports Similar to the Global Mammalian Cell Culture Market 2026, By The Business Research Company

Pulmonary Embolism Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/pulmonary-embolism-global-market-report

Esophageal Cancer Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/esophageal-cancer-global-market-report

Aortic Aneurysm Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/aortic-aneurysm-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795